The National Office of Animal Health (NOAH) elected Gaynor Hillier as its chairman for the next 12 months at its annual general meeting in London last week.

Ms Hillier, who is head of Elanco UK and Ireland, succeeds Cat Sayer of Hipra in the role. Her animal health career started at NOAH, which she joined as a technical executive in 1990. She moved to Intervet in 1994 as a marketer, working her way up to head of global marketing from 2006-2008, based in the Netherlands. In 2008, she joined Novartis in the US as vice president, marketing before being appointed head of the Novartis Animal Health UK and Irish business.

When the business was acquired by Elanco in 2014, she oversaw the integration of the two businesses in the UK and Ireland, and has lead it since January 2015. Ms Hillier has been on the NOAH board of management since 2011 and its vice-chair since 2013.

NOAH vice-chairs for the next term are Ferenc Polz of Bayer, Mary Boughton of Dorwest and David Ellerton of Virbac, with Dechra’s Mark Floyd as treasurer.)

“The past year has been one of great changes but NOAH has continued to act on behalf of our members, both as the voice of the industry and an information resource,” says Ms Hillier. “The political landscape in which we operate continues to evolve rapidly. We have reaffirmed where we need to focus – on our priorities, which are regulatory matters; explaining the role of antibiotics in caring for our animals and helping stop the rise of antibiotic resistance; working with others as the voice of our industry and serving our members better. Within these, ensuring a successful future relationship with the EU for our sector is integral.

The UK animal medicines sector can establish itself as a global centre of innovation and research, with NOAH members operating in a competitive environment, providing medicines to keep the nation’s animals healthy,” she stated.